mRNA-1273

Category

Wake Forest Baptist Health & Javara Research as a Care Option Partnership Put to the Test on the mRNA-1273 COVID-19 Vaccine Trial

By September 2018, Javara and Wake Forest Baptist Health announced their intention to deliver the clinical research as a care option to the patients of this region. Fast forward nearly two years, and the partnership now embraces a major test: it must produce results...

Arbutus Biopharma Seeks a Share of Moderna’s Revenues Should its COVID-19 Vaccine (mRNA-1273) be Approved: Patent Dispute

Moderna, the maker of mRNA-1273, one of the leading COVID-19 experimental vaccine candidates, has attracted enormous attention from investors, society, and the press, not to mention from health authorities and governments around the world. Now they have new attention:...

Accel Clinical Services to Conduct the Pivotal mRNA-1273 COVID-19 Vaccine Trial in Central Florida

Accel Clinical Services, a private equity-backed network of clinical trial sites dedicated to the expert delivery of treatment options to patients and providers, was selected to participate in the pivotal Phase 3 clinical trial sponsored by Moderna to test the safety...

Lowcountry Locally-owned Research Site Operation Carolina Clinical Research Center Selected by Moderna to Conduct Phase 3 mRNA-1273 Clinical Trial

South Carolina’s Lowcountry is gearing up to contribute to the defeat of COVID-19 by participating in the forthcoming Moderna mRNA-1273 Phase 3 clinical trial. One of 100 research sites around America, The Carolina Clinical Research Center (CCRC) establishes itself as...

Pin It on Pinterest